LPTX
Price
$0.36
Change
-$0.01 (-2.70%)
Updated
Apr 17 closing price
Capitalization
14.99M
SABS
Price
$1.44
Change
+$0.04 (+2.88%)
Updated
Apr 17 closing price
Capitalization
13.24M
Ad is loading...

LPTX vs SABS

Header iconLPTX vs SABS Comparison
Open Charts LPTX vs SABSBanner chart's image
Leap Therapeutics
Price$0.36
Change-$0.01 (-2.70%)
Volume$305.65K
Capitalization14.99M
SAB Biotherapeutics
Price$1.44
Change+$0.04 (+2.88%)
Volume$869
Capitalization13.24M
LPTX vs SABS Comparison Chart
Loading...
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LPTX vs. SABS commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPTX is a Hold and SABS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (LPTX: $0.36 vs. SABS: $1.43)
Brand notoriety: LPTX and SABS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPTX: 11% vs. SABS: 2%
Market capitalization -- LPTX: $14.99M vs. SABS: $13.24M
LPTX [@Biotechnology] is valued at $14.99M. SABS’s [@Biotechnology] market capitalization is $13.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPTX’s FA Score shows that 0 FA rating(s) are green whileSABS’s FA Score has 0 green FA rating(s).

  • LPTX’s FA Score: 0 green, 5 red.
  • SABS’s FA Score: 0 green, 5 red.
According to our system of comparison, both LPTX and SABS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPTX’s TA Score shows that 4 TA indicator(s) are bullish while SABS’s TA Score has 5 bullish TA indicator(s).

  • LPTX’s TA Score: 4 bullish, 3 bearish.
  • SABS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SABS is a better buy in the short-term than LPTX.

Price Growth

LPTX (@Biotechnology) experienced а +15.00% price change this week, while SABS (@Biotechnology) price change was +21.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

LPTX is expected to report earnings on Aug 11, 2023.

SABS is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LPTX($15M) has a higher market cap than SABS($13.2M). SABS YTD gains are higher at: -62.179 vs. LPTX (-87.360). SABS has higher annual earnings (EBITDA): -40.29M vs. LPTX (-64.24M). LPTX has more cash in the bank: 62.8M vs. SABS (30.4M). LPTX has less debt than SABS: LPTX (376K) vs SABS (4.52M). LPTX (0) and SABS (0) have equivalent revenues.
LPTXSABSLPTX / SABS
Capitalization15M13.2M114%
EBITDA-64.24M-40.29M159%
Gain YTD-87.360-62.179140%
P/E RatioN/AN/A-
Revenue00-
Total Cash62.8M30.4M207%
Total Debt376K4.52M8%
FUNDAMENTALS RATINGS
LPTX: Fundamental Ratings
LPTX
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LPTXSABS
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
55%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 5 days ago
69%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 12 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
63%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X84895.750000861.882800
+1.03%
Bitcoin cryptocurrency
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

LPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPTX has been loosely correlated with SABS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if LPTX jumps, then SABS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPTX
1D Price
Change %
LPTX100%
-1.52%
SABS - LPTX
47%
Loosely correlated
+3.24%
INKT - LPTX
39%
Loosely correlated
-7.41%
GLUE - LPTX
31%
Poorly correlated
+3.17%
EVAX - LPTX
30%
Poorly correlated
-0.08%
PLRX - LPTX
29%
Poorly correlated
+1.39%
More

SABS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SABS has been loosely correlated with LPTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SABS jumps, then LPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SABS
1D Price
Change %
SABS100%
+3.24%
LPTX - SABS
48%
Loosely correlated
-1.52%
MGX - SABS
32%
Poorly correlated
+2.70%
SLS - SABS
30%
Poorly correlated
+2.34%
INKT - SABS
30%
Poorly correlated
-7.41%
VERV - SABS
27%
Poorly correlated
+1.77%
More